<DOC>
	<DOCNO>NCT02246959</DOCNO>
	<brief_summary>In 4-arm , randomize control trial , evaluate relative effectiveness cost-effectiveness improve cholesterol level among participant high risk CVD elevate LDL cholesterol level test process versus outcomes financial incentive . Participants use electronic pill bottle continuously monitor statin adherence . The primary outcome change LDL cholesterol 12 month .</brief_summary>
	<brief_title>Process Versus Outcomes Incentives Lipid Management</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Individuals high risk cardiac event , specifically one following : Individuals clinical ASCVD ( define diagnosis myocardial infarction , stroke , peripheral vascular disease ) LDL great equal 100 mg/dl ; Individuals Diabetes ( age 4075 ) LDL great equal 100 mg/dl ; Individuals without clinical ASCVD diabetes LDLC LDL great equal 100 mg/dl estimate 10year ASCVD risk 7.5 % ; Individuals without clinical ASCVD diabetes LDL cholesterol 190 mg/dl A prescription fill statin medication within last 12 month ( derive pharmacy record ) ; Medication Possession Ratio ( MPR ) less equal 80 % A score 0 8item Morisky Medication Adherence Questionnaire complete enrollment Under 18 year old A contraindication statin use suffer statin side effect , myopathy Will give consent A history active progressive liver disease abnormal liver function test baseline screen [ Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) great 3x upper limit normal ] . Participating another clinical trial relate aim Comorbidities likely lead death within short period ( e.g . metastatic cancer )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>